tradingkey.logo
tradingkey.logo
Suchen

Lifecore Biomedical Inc

LFCR
Zur Watchlist hinzufügen
5.090USD
-0.180-3.42%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
190.76MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Lifecore Biomedical Inc Unternehmen

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc Informationen

BörsenkürzelLFCR
Name des UnternehmensLifecore Biomedical Inc
IPO-datumFeb 15, 1996
CEOJosephs (Paul)
Anzahl der mitarbeiter406
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 15
Addresse3515 Lyman Boulevard
StadtCHASKA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55318
Telefon19523684300
Websitehttps://www.lifecore.com/
BörsenkürzelLFCR
IPO-datumFeb 15, 1996
CEOJosephs (Paul)

Führungskräfte von Lifecore Biomedical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Lifecore Biomedical Inc?

Die fünf größten Anteilseigner von Lifecore Biomedical Inc sind: Mr. Paul Josephs

Wie viele Institutionen halten Anteile an Lifecore Biomedical Inc (LFCR)?

Mit Stand vom 2026Q1 halten 225 Institutionen Anteile an Lifecore Biomedical Inc, mit einem Gesamtmarktwert von etwa 30.56M, was 81.48% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1031462.00 gestiegen.

Was ist die größte Einnahmequelle von Lifecore Biomedical Inc?

Am 2026Q1 erzielte das Geschäft mit Contract development and manufacturing organization ("CDMO") für Lifecore Biomedical Inc den höchsten Umsatz in Höhe von 17.81M, was 64.53% des Gesamtumsatzes entspricht.